EPO Patents = 1

Trademarks = 1

Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Owe Orwar (4 out of 26 patents)

Benjamin Pelcman (4 out of 27 patents)

William Stafford (4 out of 4 patents)

4. Carolina Trkulja (3 out of 3 patents)

5. Edgars Suna (2 out of 10 patents)

6. Martins Priede (2 out of 2 patents)

7. Jessica Hägglund (1 out of 1 patent)

8. Max Davidson (1 out of 1 patent)

9. Kjell Andersson (1 out of 9 patents)

7 patents: Sort by Forward Citations

1. 11912765 - Methods for epitope selection (2024-02-27),

2. 11408883 - Multi-protease method (2022-08-09),

3. 11208384 - Sulfinylpyridines and their use in the treatment of cancer (2021-12-28),

4. 11168069 - Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer (2021-11-09),

5. 11161901 - Methods for epitope selection (2021-11-02),

6. 11161815 - Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer (2021-11-02),

7. 11028067 - Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer (2021-06-08),

Oblique Therapeutics Ab is a biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer. Using cutting-edge technology and innovative approaches, Oblique Therapeutics is dedicated to advancing the field of oncology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#49 in Gothenburg

#771 in Sweden

Gothenburg, Sweden

Oblique Therapeutics Ab